🚀 VC round data is live in beta, check it out!
Medicover Valuation Multiples
Discover revenue and EBITDA valuation multiples for Medicover and similar public comparables like Asker Healthcare Group, Dallah Healthcare, Global Health, Kpj Healthcare and more.
Medicover Overview
About Medicover
Medicover AB is an international healthcare and diagnostic services, provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. The company offers its services through two segments; Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas in Germany, Romania, Poland, and Ukraine; and Healthcare Services offer high-quality care based on an Integrated Healthcare Model and Fee-For-Service in Poland, India, and Romania. It generates maximum revenue from the Healthcare Services segment. Geographically, it derives a majority of its revenue from Poland and also has a presence in Romania; Germany; Ukraine; India, and Other Countries.
Founded
1995
HQ
Employees
47.3K
Website
Sectors
Financials (LTM)
EV
$5B
Medicover Financials
Medicover reported last 12-month revenue of $3B and EBITDA of $474M.
In the same LTM period, Medicover generated $664M in gross profit, $474M in EBITDA, and $99M in net income.
Revenue (LTM)
Medicover P&L
In the most recent fiscal year, Medicover reported revenue of $3B and EBITDA of $455M.
Medicover expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $664M | XXX | $649M | XXX | XXX | XXX |
| Gross Margin | 23% | XXX | 23% | XXX | XXX | XXX |
| EBITDA | $474M | XXX | $455M | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 16% | XXX | XXX | XXX |
| EBIT Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| Net Profit | $99M | XXX | $91M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | — | — | $940M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Medicover Stock Performance
Medicover has current market cap of $3B, and enterprise value of $5B.
Market Cap Evolution
Medicover's stock price is $22.19.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $3B | -0.2% | XXX | XXX | XXX | $0.60 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedicover Valuation Multiples
Medicover trades at 1.7x EV/Revenue multiple, and 10.4x EV/EBITDA.
EV / Revenue (LTM)
Medicover Financial Valuation Multiples
As of April 18, 2026, Medicover has market cap of $3B and EV of $5B.
Equity research analysts estimate Medicover's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medicover has a P/E ratio of 33.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 10.4x | XXX | 10.9x | XXX | XXX | XXX |
| EV/EBIT | 24.1x | XXX | 25.6x | XXX | XXX | XXX |
| EV/Gross Profit | 7.5x | XXX | 7.6x | XXX | XXX | XXX |
| P/E | 33.8x | XXX | 36.7x | XXX | XXX | XXX |
| EV/FCF | 48.4x | XXX | 22.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medicover Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Medicover Margins & Growth Rates
Medicover's revenue in the last 12 month grew by 11%.
Medicover's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Medicover's rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medicover's rule of X is 47% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Medicover Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 14% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 29% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 47% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 4% | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | 12% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 16% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Medicover Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Medicover | XXX | XXX | XXX | XXX | XXX | XXX |
| Asker Healthcare Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Dallah Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Global Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Kpj Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Meinian Onehealth | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medicover M&A Activity
Medicover acquired XXX companies to date.
Last acquisition by Medicover was on XXXXXXXX, XXXXX. Medicover acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Medicover
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMedicover Investment Activity
Medicover invested in XXX companies to date.
Medicover made its latest investment on XXXXXXXX, XXXXX. Medicover invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Medicover
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medicover
| When was Medicover founded? | Medicover was founded in 1995. |
| Where is Medicover headquartered? | Medicover is headquartered in Sweden. |
| How many employees does Medicover have? | As of today, Medicover has over 47K employees. |
| Who is the CEO of Medicover? | Medicover's CEO is Fredrik Ragmark. |
| Is Medicover publicly listed? | Yes, Medicover is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Medicover? | Medicover trades under MCOV B ticker. |
| When did Medicover go public? | Medicover went public in 2017. |
| Who are competitors of Medicover? | Medicover main competitors are Asker Healthcare Group, Dallah Healthcare, Global Health, Kpj Healthcare. |
| What is the current market cap of Medicover? | Medicover's current market cap is $3B. |
| What is the current revenue of Medicover? | Medicover's last 12 months revenue is $3B. |
| What is the current revenue growth of Medicover? | Medicover revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Medicover? | Current revenue multiple of Medicover is 1.7x. |
| Is Medicover profitable? | Yes, Medicover is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Medicover? | Medicover's last 12 months EBITDA is $474M. |
| What is Medicover's EBITDA margin? | Medicover's last 12 months EBITDA margin is 16%. |
| What is the current EV/EBITDA multiple of Medicover? | Current EBITDA multiple of Medicover is 10.4x. |
| What is the current FCF of Medicover? | Medicover's last 12 months FCF is $102M. |
| What is Medicover's FCF margin? | Medicover's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Medicover? | Current FCF multiple of Medicover is 48.4x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.